Paola Tiberio graduated in 2004 in Biotechnology at the II University of Milan-Bicocca with a thesis entitled “Study of the structural properties and in silico mutagenesis of the granulocyte colony-stimulating factor” performed at the II University of Milan-Bicocca. In 2006, Paola Tiberio got a specialization degree in Industrial Biotechnology at the II University of Milan-Bicocca (110/110) with a thesis entitled “Role of PLAB in the apoptosis induced by the synthetic retinoid fenretinide in ovarian cancer cells.” performed at the Chemoprevention Unit of the Fondazione IRCCS Istituto Nazionale dei Tumori in Milan. Paola Tiberio's Present position is Clinical Research - Medical Oncology and Hematology Unit, IRCCS Humanitas Research Hospital, Rozzano (MI), Italy. Paola Tiberio has been Senior Fellow at Biomarker Unit, Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy 2010-2016; Fellow at Chemoprevention Unit, Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan 2006-2010. Paola Tiberio has 24 publications, including 10 papers as first author, 1 as corresponding, and 1 as last author, and a European patent entitled “4-oxo-N-(4-chydroxypchenyl)retnamide Derivatives As Therapeutic Agents For The Treatment Of Cancer” (EP3194360).